Alnylam Pharmaceuticals
ALNY
#622
Rank
$31.76 B
Marketcap
$246.27
Share price
-1.16%
Change (1 day)
30.61%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company